|
|
|
|
|||||
|
|
|
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 6th:
MAIA Biotechnology, Inc. MAIA: This immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.4% over the last 60 days.
MAIA Biotechnology, Inc. price-consensus-chart | MAIA Biotechnology, Inc. Quote
MAIA’s shares gained 0.5% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score of A.
MAIA Biotechnology, Inc. price | MAIA Biotechnology, Inc. Quote
Byrna Technologies Inc. BYRN: This non-lethal defense technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 25% overthe last 60 days.
Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote
Byrna’s shares gained 33.8% over the last six months compared with the S&P 500’s decline of 4.7%. The company possesses a Momentum Score of B.
Byrna Technologies Inc. price | Byrna Technologies Inc. Quote
OncoCyte Corporation OCX: This precision diagnostics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.3% over the last 60 days.
OncoCyte Corporation price-consensus-chart | OncoCyte Corporation Quote
OncoCyte’s shares gained 45.3% over the last three months compared with the S&P 500’s decline of 5.6%. The company possesses a Momentum Score of B.
OncoCyte Corporation price | OncoCyte Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 13 hours | |
| 16 hours | |
| 23 hours | |
| May-05 | |
| May-05 | |
| May-01 | |
| Apr-30 | |
| Apr-29 | |
| Apr-28 | |
| Apr-27 | |
| Apr-24 | |
| Apr-24 | |
| Apr-22 | |
| Apr-21 | |
| Apr-16 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite